10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2018 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2018 10-K (Filed: Feb 26, 2019) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | |
| Revenues | |||
| Revenues | $ 22,127 | 26,107 | 30,390 |
| Costs and Expenses | |||
| Cost of goods sold | 4,853 | 4,371 | 4,261 |
| Research and development expenses | 5,018 | 3,734 | 5,098 |
| Selling, general and administrative expenses | 4,056 | 3,878 | 3,398 |
| Total costs and expenses | 13,927 | 11,983 | 12,757 |
| Income from operations | 8,200 | 14,124 | 17,633 |
| Interest expense | (1,077) | (1,118) | (964) |
| Other income (expense), net | 676 | 523 | 428 |
| Income before provision for income taxes | 7,799 | 13,529 | 17,097 |
| Provision for income taxes | 2,339 | 8,885 | 3,609 |
| Net income | 5,460 | 4,644 | 13,488 |
| Net income (loss) attributable to noncontrolling interest | 5 | 16 | (13) |
| Net income attributable to Gilead | 5,455 | 4,628 | 13,501 |
| Net income per share attributable to Gilead common stockholders - basic | 4.20 | 3.54 | 10.08 |
| Shares used in per share calculation - basic | 1,298 | 1,307 | 1,339 |
| Net income per share attributable to Gilead common stockholders - diluted | 4.17 | 3.51 | 9.94 |
| Shares used in per share calculation - diluted | 1,308 | 1,319 | 1,358 |
| Product and Service | |||
| Product sales | |||
| Revenues | 21,677 | 25,662 | 29,953 |
| Royalty, contract and other revenues | |||
| Revenues | 450 | 445 | 437 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2018 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |